EMA and Swissmedic agree on further Cooperation

Recommendation

19/20 October 2021

GMP for Beginners - Understanding the Importance of GMP - Live Online

The European Medicines Agency (EMA), the Directorate General Health and Food Safety (DG SANTE) of the European Commission and the Swissmedic signed an agreement which aims at ensuring a better exchange of non-public information for the protection of the public health. It is intended to exchange information related to the safety, quality or efficacy of medicines which are either already approved or in the authorisation process in the EU or in Switzerland. A similar agreement existed in 2009/2010 at the time of the H1N1 pandemic. The new agreement has been effective since the 10 July 2015 and will be valid for five years.

To find out more please see the original note on the page of the Swissmedic.